271 related articles for article (PubMed ID: 10193411)
41. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
42. Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
Goetz M; Schiel X; Heussel H; Steinmetz T; Hiddemann W; Weiss M
Eur J Med Res; 2002 Nov; 7(11):487-90. PubMed ID: 12568977
[TBL] [Abstract][Full Text] [Related]
43. Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.
Gustavsson C; Agardh CD; Agardh E
Acta Ophthalmol; 2013 Aug; 91(5):445-52. PubMed ID: 22520269
[TBL] [Abstract][Full Text] [Related]
44. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
45. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
[TBL] [Abstract][Full Text] [Related]
46. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
47. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
Zhang D; Li J; Jiang Z; Yu B; Tang X
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
[TBL] [Abstract][Full Text] [Related]
48. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
[TBL] [Abstract][Full Text] [Related]
49. Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women.
Tsukui S; Kanda T; Nara M; Nishino M; Kondo T; Kobayashi I
Int J Obes Relat Metab Disord; 2000 Sep; 24(9):1207-11. PubMed ID: 11033992
[TBL] [Abstract][Full Text] [Related]
50. [Tumor necrosis factor alpha (TNF-alpha) and its receptors: sTNF-alphaRI i sTNF-alphaRII in chronic pancreatitis].
Daniel P; Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Arch Med Wewn; 2005 Jul; 114(1):639-43. PubMed ID: 16466009
[TBL] [Abstract][Full Text] [Related]
51. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
52. Tumour necrosis factor α-308 G/a and -238 G/a polymorphisms as predicator of diabetic retinopathy in Egyptians.
Moemen LAAA; El Shahat Ebeid M; A Abdelazeem A; Kenawy M Kenawy M; M Osman Z
Arch Physiol Biochem; 2023 Oct; 129(5):1143-1151. PubMed ID: 33910435
[TBL] [Abstract][Full Text] [Related]
53. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
54. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
55. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
Adamiec-Mroczek J; Oficjalska-Młyńczak J
Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1665-70. PubMed ID: 18682976
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.
Corti A; Fattorini L; Thoresen OF; Ricci ML; Gallizia A; Pelagi M; Li Y; Orefici G
Infect Immun; 1999 Nov; 67(11):5762-7. PubMed ID: 10531226
[TBL] [Abstract][Full Text] [Related]
57. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
Patzold T; Sindern E; Ossege-Pohle L; Malin JP
J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
[TBL] [Abstract][Full Text] [Related]
58. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
Loppnow H; Werdan K; Werner C
Auton Autacoid Pharmacol; 2002 Apr; 22(2):83-92. PubMed ID: 12568125
[TBL] [Abstract][Full Text] [Related]
59. Plasma levels of tumor necrosis factor-alpha and its receptors in patients with mitral stenosis and sinus rhythm undergoing percutaneous balloon valvuloplasty.
Cagli KE; Aras D; Topaloglu S; Geyik B; Ayaz S; Cagirci G; Kisacik HL; Korkmaz S
Heart Vessels; 2010 Mar; 25(2):131-7. PubMed ID: 20339974
[TBL] [Abstract][Full Text] [Related]
60. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
